Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Sanara Medtech Inc - SIC # 2834 - PHARMACEUTICAL PREPARATIONS
Ticker
Exchange
SIC #
Website
Latest Ticker
SMTI
Nasdaq
2834
https://sanaramedtech.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Sanara Medtech Inc
Sanara MedTech Inc (SMTI) Q1 2024 Earnings Call Transcript Highlights: Navigating Growth Amid ...
- May 15th, 2024 7:05 am
Sanara MedTech Inc. Reports First Quarter 2024 Results: Revenue Surges, Losses Widen
- May 13th, 2024 2:52 pm
Sanara MedTech Inc. Announces First Quarter 2024 Results
- May 13th, 2024 1:15 pm
Insiders own 30% of Sanara MedTech Inc. (NASDAQ:SMTI) shares but individual investors control 32% of the company
- May 12th, 2024 2:00 pm
Sanara MedTech Inc. Announces First Quarter Earnings Release and Conference Call Dates
- Apr 29th, 2024 1:15 pm
Sanara MedTech Inc. Announces $55 Million Debt Facility
- Apr 18th, 2024 1:15 pm
Sanara MedTech Inc. Announces the Appointments of Jake Waldrop as Chief Operating Officer and Tyler Palmer as Chief Corporate Development and Strategy Officer
- Apr 5th, 2024 1:00 pm
Sanara MedTech Inc (SMTI) Reports Strong Sales Growth and Reduced Net Loss for Full Year 2023
- Mar 25th, 2024 9:52 pm
Sanara MedTech Inc. Announces Fourth Quarter and Full Year 2023 Results
- Mar 25th, 2024 8:05 pm
Investors in Sanara MedTech (NASDAQ:SMTI) have seen fantastic returns of 541% over the past five years
- Mar 13th, 2024 1:42 pm
Sanara MedTech Inc. Announces Fourth Quarter and Full Year 2023 Earnings Release and Conference Call Dates
- Mar 13th, 2024 1:15 pm
Sanara MedTech Inc. Announces Unaudited Preliminary Results for the Fourth Quarter and Full Year 2023
- Feb 22nd, 2024 2:15 pm
Sanara MedTech Inc. (NASDAQ:SMTI) About To Shift From Loss To Profit
- Jan 5th, 2024 10:23 am
Sanara MedTech Inc. Announces Exclusive License Agreement for Patented Collagen Peptides
- Jan 3rd, 2024 2:15 pm
Sanara MedTech Inc.'s (NASDAQ:SMTI) top owners are retail investors with 32% stake, while 31% is held by insiders
- Dec 4th, 2023 1:40 pm
Sanara MedTech Inc. Announces the Publication of a 5,335 Patient Study Demonstrating a Significant Reduction in Surgical Site Infections When Activated Collagen (CellerateRX® Surgical Powder) Was Used to Promote Wound Healing
- Nov 30th, 2023 2:15 pm
Sanara MedTech Inc. Reports Record Sales in Q3 2023 with Narrowed Net Loss and Positive ...
- Nov 13th, 2023 10:29 pm
Sanara MedTech Inc. Announces Third Quarter 2023 Results
- Nov 13th, 2023 9:05 pm
Sanara MedTech Inc. Announces Third Quarter Earnings Release and Conference Call Dates
- Oct 30th, 2023 1:15 pm
Sanara MedTech Announces First Sale of ALLOCYTE® Plus Advanced Viable Bone Matrix and Provides Other Product Updates
- Oct 10th, 2023 1:15 pm
Scroll